Skip to main content

Hip Replacement Surgery

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Baxter International
1 program
Fibrin Sealant Vapor-Heated Solvent/Detergent-treatedPHASE_31 trial
Active Trials
NCT00161902CompletedEst. Mar 2003

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Baxter InternationalFibrin Sealant Vapor-Heated Solvent/Detergent-treated

Clinical Trials (1)

NCT00161902Baxter InternationalFibrin Sealant Vapor-Heated Solvent/Detergent-treated

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip Replacement

Start: Aug 2001Est. completion: Mar 2003
Phase 3Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.